The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain

Biochemistry

Volumn 45, Issue 17, 2006, Pages 5551-5556

  You, Min ^a   Li, Edwin ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL MEMBRANES; DETERGENTS; DIMERIZATION; DISEASES; LIPIDS; MICELLES;

ACHONDROPLASIA; ARG380-MEDIATED FGFR3 DIMER STABILIZATION; FIBROBLAST GROWTH FACTOR; PHENOTYPE INDUCTION;

MUTAGENESIS;

ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCINE; MUTANT PROTEIN;

ACHONDROPLASIA; ARTICLE; DIMERIZATION; DOWN REGULATION; DWARFISM; ENERGY TRANSFER; HUMAN; LIPID BILAYER; MICELLE; MOLECULAR STABILITY; MULTIGENE FAMILY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION;

ACHONDROPLASIA; AMINO ACID SEQUENCE; CIRCULAR DICHROISM; DIMERIZATION; DOWN-REGULATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIPID BILAYERS; MICELLES; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 33646347414     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060113g     Document Type: Article

References (39)

1. Vajo, Z., Francomano, C. A., and Wilkin, D. J. (2000) The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans, Endocr. Rev. 21, 23-39.
2. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth, Cell 84, 911-921.
3. Nguyen, H. B., Estacion, M., and Gargus, J. J. (1997) Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts, Hum. Mol. Genet. 6, 681-688.
4. Ponseti, I. V. (1970) Skeletal growth in achondroplasia, J. Bone Jt. Surg., Am. Vol. A 52, 701.
5. Maynard, J. A., Ippolito, E. G., Ponseti, I. V., and Mickelson, M. R. (1981) Histochemistry and ultrastructure of the growth plate in achondroplasia, J. Bone Jt. Surg., Am. Vol. 63, 969-979.
6. Colvin, J. S., Bohne, B. A., Harding, G. W., Mcewen, D. G., and Ornitz, D. M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3, Nat. Genet. 12, 390-397.
7. Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia, Cell 78, 335-342.
8. Wilkie, A. O. M., Morriss-Kay, G. M., Jones, E. Y., and Heath, J. K. (1995) Functions of fibroblast growth factors and their receptors, Curr. Biol. 5, 500-507.
9. L'Horte, C. G. M., and Knowles, M. A. (2005) Cell responses to FGFR3 signaling: growth, differentiation and apoptosis, Exp. Cell Res. 304, 417-431.
10. Spivakkroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. (1994) Heparin-induced oligomerization of Fgf molecules is responsible for Fgf receptor dimerization, activation, and cell-proliferation, Cell 79, 1015-1024.
11. Webster, M. K., and Donoghue, D. J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia, EMBO J. 15, 520-527.
12. Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O., and Yayon, A. (2000) The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation, Mol. Cell. Biol. 20, 516-522.
13. Cho, J. Y., Guo, C. S., Torello, M., Lunstrum, G. P., Iwata, T., Deng, C. X., and Horton, W. A. (2004) Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia, Proc. Natl. Acad. Sci. U.S.A. 101, 609-614.
14. Li, E., You, M., and Hristova, K. (2005) SDS-PAGE and FRET suggest weak interactions between FGFR3 TM domains in the absence of extracellular domains and ligands, Biochemistry 44, 352-360.
15. Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., and Jabs, E. W. (1995) Fibroblast-growth-factor-receptor-3 (Fgfr3) transmembrane mutation in Crouzon-syndrome with acanthosis nigricans, Nat. Genet. 11, 462-464.
16. van Rhijin, B., van Tilborg, A., Lurkin, I., Bonaventure, J., de Vries, A., Thiery, J. P., van der Kwast, T. H., Zwarthoff, E., and Radvanyi, F. (2002) Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders, Eur. J. Hum. Genet. 10, 819-824.
17. Li, E., You, M., and Hristova, K. (2006) FGFR3 dimer stabilization due to a single amino acid pathogenic mutation, J. Mol. Biol. 356, 600-612.
18. Merzlyakov, M., You, M., Li, E., and Hristova, K. (2006) Transmembrane helix heterodimerization in lipids bilayers: probing the energetics behind autosomal dominant growth disorders, J. Mol. Biol. 358, 1-7.
19. Monsonego-Ornan, E., Adar, R., Rom, E., and Yayon, A. (2002) FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation, FEBS Lett. 528, 83-89.
20. Jayasinghe, S., Hristova, K., and White, S. H. (2001) Energetics, stability, and prediction of transmembrane helices, J. Mol. Biol. 312, 927-934.
21. Iwamoto, T., You, M., Li, E., Spangler, J., Tomich, J. M., and Hristova, K. (2005) Synthesis and initial characterization of FGFR3 transmembrane domain: Consequences of sequence modifications, Biochim. Biophys. Acta 1668, 240-247.
22. Sharon, M., Oren, Z., Shai, Y., and Anglister, J. (1999) 2D-NMR and ATR-FTIR study of the structure of a cell-selective diastereomer of melittin and its orientation in phospholipids, Biochemistry 38, 15305-15316.
23. Hetru, C., Letellier, L., Oren, Z., Hoffmann, J. A., and Shai, Y. (2000) Androctonin, a hydrophilic disulphide-bridged non-haemolytic anti-microbial peptide: a plausible mode of action, Biochem. J. 345, 653-664.
24. + channel ROMK1, Biochem. J. 335, 375-380.
25. Li, E., and Hristova, K. (2004) Imaging FRET measurements of transmembrane helix interactions in lipid bilayers on a solid support, Langmuir 20, 9053-9060.
26. You, M., Li, E., Wimley, W. C., and Hristova, K. (2005) FRET in liposomes: measurements of TM helix dimerization in the native bilayer environment, Anal. Biochem. 340, 154-164.
27. Vogel, H. (1987) Comparison of the conformation and orientation of alamethicin and melittin in lipid membranes, Biochemistry 26, 4562-4572.
28. Olah, G. A., and Huang, H. W. (1988) Circular dichroism of oriented α helices. I. Proof of the exciton theory, J. Chem. Phys. 89, 2531-2538.
29. Olah, G. A., and Huang, H. W. (1988) Circular dichroism of oriented α helices. II. Electric field oriented polypeptides, J. Chem. Phys. 89, 6956-6962.
30. Hristova, K., Wimley, W. C., Mishra, V. K., Anantharamaiah, G. M., Segrest, J. P., and White, S. H. (1999) An amphipathic α-helix at a membrane interface: A structural study using a novel X-ray diffraction method, J. Mol. Biol. 290, 99-117.
31. Hristova, K., Dempsey, C. E., and White, S. H. (2001) Structure, location, and lipid perturbations of melittin at the membrane interface, Biophys. J. 80, 801-811.
32. Hessa, T., White, S. H., and von Heijne, G. (2005) Membrane insertion of a potassium-channel voltage sensor, Science 307, 1427.
33. Wu, Y., Huang, H. W., and Olah, G. A. (1990) Method of oriented circular dichroism, Biophys. J. 57, 797-806.
34. Lemmon, M. A., Flanagan, J. M., Hunt, J. F., Adair, B. D., Bormann, B. J., Dempsey, C. E., and Engelman, D. M. (1992) Glycophorin-A dimerization is driven by specific interactions between transmembrane α-helices, J. Biol. Chem. 267, 7683-7689.
35. Russ, W. P., and Engelman, D. M. (1999) TOXCAT: A measure of transmembrane helix association in a biological membrane, Proc. Natl. Acad. Sci. U.S.A. 96, 863-868.
36. Sulistijo, E. S., Jaszewski, T. M., and MacKenzie, K. R. (2003) Sequence-specific dimerization of the transmembrane domain of the "BH3-only" protein BNIP3 in membranes and detergent, J. Biol. Chem. 278, 51950-51956.
37. Adair, B. D., and Engelman, D. M. (1994) Glycophorin a helical transmembrane domains dimerize in phospholipid bilayers-a resonance energy transfer study, Biochemistry 33, 5539-5544.
38. Li, M., Reddy, L. G., Bennett, R., Silva, N. D., Jr., Jones, L. R., and Thomas, D. D. (1999) A fluorescence energy transfer method for analyzing protein oligomeric structure: Application to phospholamban, Biophys. J. 76, 2587-2599.
39. Wolber, P. K., and Hudson, B. S. (1979) An analytic solution to the Förster energy transfer problem in two dimensions, Biophys. J. 28, 197-210.